SCHEMBL6132051

SCHEMBL6132051

Nc1n[nH]c(-c2ccncc2)c1-c1ccccc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.83
NPSR1 Q6W5P4 1/20 0.83
MAPK14 Q16539 1/20 0.71
RPS6KA3 P51812 2/20 0.69
ILK Q13418 4/20 0.58
AKT2 P31751 1/20 0.54
KMT2A Q03164 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.50
CYP3A4 P08684 1/20 0.48
AURKA O14965 1/20 0.47
CDK1 P06493 1/20 0.47
LYN P07948 1/20 0.47
PIM1 P11309 1/20 0.47
FGFR1 P11362 1/20 0.47
PRKACA P17612 1/20 0.47
RPS6KB1 P23443 1/20 0.47
CDK2 P24941 1/20 0.47
MARK3 P27448 1/20 0.47
AKT1 P31749 1/20 0.47
GSK3B P49841 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5820038 0.91 MAPK1 (1.00) MAPK1NPSR1MAPK14RPS6KA3ILK
SCHEMBL6179977 0.83 MAPK14 (1.00) MAPK1NPSR1MAPK14RPS6KA3ILK
SCHEMBL6076585 0.83 MAPK14 (1.00) MAPK1NPSR1MAPK14RPS6KA3ILK
SCHEMBL1013845 0.82 CYP3A4 (0.61) MAPK1NPSR1MAPK14RPS6KA3ILK
SCHEMBL6132067 0.81 MAPK1 (0.80) MAPK1NPSR1MAPK14RPS6KA3ILK
SCHEMBL6132080 0.81 MAPK1 (0.80) MAPK1NPSR1MAPK14RPS6KA3ILK
SCHEMBL6132076 0.81 MAPK1 (0.80) MAPK1NPSR1MAPK14RPS6KA3ILK
SCHEMBL6132022 0.81 MAPK1 (0.80) MAPK1NPSR1MAPK14RPS6KA3ILK
SCHEMBL6219367 0.79 MAPK1 (0.51) MAPK1NPSR1MAPK14RPS6KA3ILK
SCHEMBL5253523 0.79 AKT2 (0.58) MAPK1NPSR1MAPK14RPS6KA3ILK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP disclosed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP disclosed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO disclosed